Last reviewed · How we verify

Buccal misoprostol

Gynuity Health Projects · FDA-approved active Small molecule ✓ Verified May 2026 Quality 2/100

Buccal misoprostol is a Small molecule drug developed by Gynuity Health Projects. It is currently FDA-approved. Also known as: cytotec, Cytotec, Buccal Cytotec.

Buccal misoprostol is a small molecule used to manage first trimester missed abortion, as well as induced abortion and abortion in the second trimester. It is administered via the buccal route, which involves placing the medication between the cheek and gum.

At a glance

Generic nameBuccal misoprostol
Also known ascytotec, Cytotec, Buccal Cytotec
SponsorGynuity Health Projects
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Buccal misoprostol

What is Buccal misoprostol?

Buccal misoprostol is a Small molecule drug developed by Gynuity Health Projects.

Who makes Buccal misoprostol?

Buccal misoprostol is developed and marketed by Gynuity Health Projects (see full Gynuity Health Projects pipeline at /company/gynuity-health-projects).

Is Buccal misoprostol also known as anything else?

Buccal misoprostol is also known as cytotec, Cytotec, Buccal Cytotec.

What development phase is Buccal misoprostol in?

Buccal misoprostol is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing